IndiaThe Indian Union Health and Family Welfare Ministry has amended the Drugs Rules, 1945, to enhance regulatory oversight of pharmaceutical companies. The changes allow licensing authorities to debar firms that submit fake or fabricated data during drug evaluations, which previously resulted in application rejections or license cancellations. The amendments aim to improve the integrity and transparency of the drugs regulatory system by imposing stricter penalties and ensuring that drug approvals are based on reliable scientific evidence. The ministry emphasized that these measures align with global best practices and complement ongoing regulatory reforms in the pharmaceutical sector.
Bias read (Center): The article presents the government's initiative as a regulatory enhancement aimed at improving public health and industry standards. While the subject involves government regulation of a critical sector, the framing remains neutral, focusing on procedural updates and alignment with international实践.
-U33638501473jaY-1200x630%40diario_abc.jpg&w=3840&q=75&output=webp&we)